Week 3A

Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. It is characterized by a profound disconnection from reality, which can lead to significant impairment in social and occupational functioning.
The disorder is marked by faulty perception (e.g., hallucinations), beliefs (e.g., delusions), emotional expressiveness, cognition, and disordered thinking. Symptoms can present differently among individuals, contributing to the complexity of diagnosis and treatment.
Symptoms fall into three main categories: positive, negative, and disorganized. Positive symptoms represent an excess or distortion of normal functions, negative symptoms reflect a decrease in normal functions, and disorganized symptoms disrupt normal behavior and thought processes.
The lifetime risk of developing schizophrenia is approximately 7 in 1000 individuals in the general population, with an equal prevalence in men and women. However, prevalence rates are notably higher in urban settings, possibly due to factors such as environmental stressors and social disintegration.
There is a concerning suicide risk associated with schizophrenia, with rates indicating that 5% to 6% of those diagnosed ultimately die by suicide, while approximately 20% will attempt suicide at some point in their lives.

Delusions: These are firmly held false beliefs that remain unchanged despite contrary evidence. Common types include grandiosity (believing one has exceptional abilities) and delusions of control (believing that one's thoughts or actions are being controlled by external forces).
Hallucinations: These sensory experiences occur in the absence of external stimuli. Auditory hallucinations (e.g., hearing voices) are the most common type, but visual, olfactory, and tactile hallucinations are also possible.
Disorganized Thinking and Behavior: This includes fragmented or incoherent speech (disorganized speech), which may manifest as tangentiality (going off on tangents) or word salad (incoherent mix of words). Behavior can also appear chaotic or disorganized, potentially leading to conditions such as catatonia, where individuals may become unresponsive or exhibit abnormal motor behavior.

Avolition: A prominent lack of motivation to initiate and sustain activities, affecting personal hygiene, work, and social interactions.
Anhedonia: The reduced ability to experience pleasure from activities that are usually found enjoyable, leading to social withdrawal and diminished interest.
Alogia: Characterized by a reduction in speech output, which can be indicative of underlying thought disorders or emotional blunting.
Asociality: This refers to the lack of interest in social interactions, leading to isolation and withdrawal from relationships.
Blunted Affect: A noticeable reduction in emotional expressiveness, where individuals may appear unresponsive or emotionally flat, affecting their ability to communicate feelings effectively.

A diagnosis of schizophrenia necessitates the presence of two or more of the following symptoms for a significant portion of one month (or less if treated):
1. Delusions
2. Hallucinations
3. Disorganized speech
4. Grossly disorganized behavior
5. Negative symptoms
Symptoms must significantly impair functioning in social or occupational contexts and persist for a minimum duration of six months, including at least one month of characteristic symptoms.

Genetic Factors: There is a notable heritable component, with a higher risk in individuals with a family history of schizophrenia, indicating that behavioral and molecular genetic influences play a role in its development.
Environmental Factors: Important factors include socio-economic status, exposure to trauma, and migration, which can contribute to the onset and progression of the disorder.
Neuroscience: Neurobiological aspects involve disruption in neurotransmitter systems, especially dopamine, along with abnormalities in brain structure and function, including alterations in regions responsible for cognition and emotion regulation.

Medications: Antipsychotic medications, categorized into 1st generation (typical) and 2nd generation (atypical), are primarily used to target positive symptoms. While they can be effective, they may have side effects that require careful monitoring.
Psychological Treatments: Various therapeutic approaches, including cognitive-behavioral therapy (CBT) to address distorted beliefs and improve coping strategies, social skills training to enhance interpersonal interactions, psychoeducation for both patients and families, family therapy to address relational dynamics, and supported employment programs that assist individuals in securing and maintaining jobs, contribute to a comprehensive treatment plan.

Providing culturally sensitive care is crucial to effectively addressing and managing schizophrenia in diverse populations, as cultural beliefs and practices can influence symptom expression, help-seeking behavior, and compliance with treatment.
Understanding the historical trauma and psychosocial realities affecting individuals can enhance the assessment and management of schizophrenia, aiding in the development of trust and rapport between patients and healthcare providers.